Dr. Mark Peter Andreozzi , DO
Otolaryngology • Warwick, RI
3520 Post Rd
Warwick, RI 028867140
This profile restates public CMS/NPPES data; T-MedInfo gives no medical advice — consult a licensed professional, and call 911 for emergencies.
-
NPI assigned on January 5, 2007; this date does not establish years in practice.
-
Published CMS data list 1,054 Original Medicare Part B services in 2024.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024. Published rows only; this is not a quality measure.
-
Published Part B service records, 2024:
- 99213 — Established patient outpatient office visit: 380 service units.
- 99214 — Established patient outpatient office visit: 185 service units.
- 31231 — Diagnostic exam of nasal passages using an endoscope: 147 service units.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024. Units differ by code; these are not visits or a measure of quality.
CPT® only copyright 2023 American Medical Association. All rights reserved. Service names are shortened from CPT Consumer Friendly Descriptors (CMS data, 2024). CPT notice
See all 11 records in the table · Guide: How to read Medicare Part B data
-
Published CMS data list 1,883 Medicare Part D prescriptions, including refills, in 2024.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Published rows only; this is not a quality measure.
-
Published Part D records, 2024:
- Fluticasone Propionate — 509 prescription fills, including refills.
- Ipratropium Bromide — 332 prescription fills, including refills.
- Azelastine Hcl — 266 prescription fills, including refills.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Drug names come from pharmacy claims. Listing a drug here is not an endorsement or a recommendation.
See all 29 records in the table · Guide: How to read Medicare Part D prescriber data
-
Close to the middle for Medicare Part B services among clinicians listed under Otolaryngology in Rhode Island (2024, 20 clinicians with data). Median for this group: 1,043. Middle half: 347 to 1,719.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024. Billing and prescribing volume is not a quality rating.
-
Medicare Part B services went from 861 in 2020 to 1,054 in 2024.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2020–2024.
Practice Location & Contact Primary Location
3520 Post Rd
Warwick, RI 028867140
Matched by practice address or phone in NPPES. A shared address or phone does not confirm that this clinician works there.
CMS Doctors and Clinicians lists 1 group name: Ent And Allergy Inc. See the list
Source: CMS Doctors and Clinicians National Downloadable File, release date unavailable.
Listings do not confirm current availability, employment or a shared ownership network.
Medicare Profile & Education
Source: CMS Doctors and Clinicians National Downloadable File
University Of New England, College Of Osteo Medicine
1987
What Public CMS Data Show
Otolaryngology: NPPES taxonomy is a reported classification, not proof of board certification.
Medicare patients
503 people with Original Medicare in 2024
It gives a sense of how many people with Medicare this clinician treated that year.
Source: CMS, Medicare Physician & Other Practitioners – by Provider, 2024.
Medicare-allowed amount
About $116,089 in 2024
The total amount Medicare approved for these services in 2024. It includes what Medicare paid and what patients or their other insurance owed, such as the deductible and coinsurance.
It shows the total cost of this clinician's Original Medicare services under Medicare's fee rules.
What this does not show: Medicare-allowed amount
This is not the clinician's income. Part of it can go to a clinic or group practice, staff, equipment or drugs. It is not the price you will pay.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024.
Paid by Medicare
About $86,106 in 2024
The part of the Medicare-allowed amount that Medicare itself paid in 2024, after patients' deductibles and coinsurance.
The gap between the allowed amount and this number is roughly what patients and their other insurance paid.
What this does not show: Paid by Medicare
This is not the clinician's income and not a measure of quality.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024.
30-day fills
3,351 standardized 30-day fills in 2024
CMS converts prescriptions to 30-day supplies so they can be compared. A 90-day prescription counts as about three 30-day fills.
What this does not show: 30-day fills
It is not a count of patients and not a measure of quality.
Part D drug cost
$295,363 in 2024
The total cost of these prescriptions in 2024, paid by Medicare drug plans, patients and other payers together.
It shows the total spending on drugs this clinician prescribed, not what any one patient paid.
What this does not show: Part D drug cost
A higher cost often reflects the type of medicines a specialty uses. It is not your out-of-pocket cost and not a measure of quality.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024.
Open Payments general payments, program year 2025
All general payments: $2,766.76 across 92 records.
By nature of payment
- Food and Beverage: $2,766.76 across 92 records.
Reporting-company totals (3 largest of 13)
- AstraZeneca Pharmaceuticals LP: $999.96 across 32 records.
- GlaxoSmithKline, LLC.: $526.87 across 18 records.
- Sanofi and Genzyme US Companies: $524.82 across 17 records.
A reported payment does not necessarily mean the financial relationship is improper and is not a measure of care quality. Clinicians can review and dispute these records.
Source: Calculated by T-MedInfo from CMS Open Payments general-payment records for program year 2025 (published June 30, 2026).
Years since graduation
39 years (graduated 1987)
CMS Doctors and Clinicians data list 1987 as the year this clinician finished professional school.
It tells you roughly how long ago the clinician finished school.
What this does not show: Years since graduation
It is not the number of years in practice, and more years does not mean better care.
Source: CMS Doctors and Clinicians National Downloadable File.
NPI first issued
2007
The year this clinician's National Provider Identifier (NPI) was issued. An NPI is a unique 10-digit ID that US health care providers use for billing.
What this does not show: NPI first issued
NPIs have been issued only since 2005, so this year is not necessarily when the clinician started practicing.
Source: CMS NPPES NPI Registry.
Accepts Medicare assignment
CMS data list this clinician as accepting Medicare assignment. This means agreeing to take the Medicare-approved amount as full payment for covered services.
With Original Medicare, you usually pay only your deductible and coinsurance, and the office sends the claim to Medicare for you.
Medicare assignment applies to Original Medicare. It does not tell you whether the clinician is in a Medicare Advantage plan's network, accepts other insurance, or is taking new patients.
Source: CMS Doctors and Clinicians; Medicare.gov, “Does your provider accept Medicare as full payment?”
No telehealth indicator
CMS shows this indicator only when recent Medicare claims include telehealth services. The clinician may still offer telehealth; ask the office.
Source: CMS, Telehealth Indicator on Medicare Care Compare (fact sheet, January 2023); CMS Doctors and Clinicians.
Enrolled in Medicare (PECOS)
Dr. Andreozzi has a Medicare enrollment record in PECOS, the CMS system clinicians use to enroll so they can bill Medicare or order services for people with Medicare.
It does not show whether the clinician accepts assignment, is in your plan's network, or is taking new patients.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Can order Medicare-covered services
CMS lists Dr. Andreozzi as eligible to order or refer Medicare Part B clinical laboratory and imaging services, durable medical equipment (DME) and home health services for people with Medicare.
Medicare pays for these items and services only when they are ordered by an eligible clinician.
What this does not show: Can order Medicare-covered services
It does not mean the clinician offers these services directly.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Compared with the same specialty in Warwick and Rhode Island
Billing and prescribing volume is not a quality rating.
Medicare Part B services
Close to the middle for clinicians listed under Otolaryngology in Rhode Island (2024, 20 clinicians with data). Median for this group: 1,043. Middle half: 347 to 1,719.
Too few clinicians listed under Otolaryngology in Warwick have Medicare Part B data for 2024 to compare.
Medicare-allowed amount
A higher Medicare-allowed amount than 65% of clinicians listed under Otolaryngology in Rhode Island (2024, 20 clinicians with data). Median for this group: $93,920. Middle half: $25,561 to $122,308.
Too few clinicians listed under Otolaryngology in Warwick have Medicare Part B data for 2024 to compare.
Paid by Medicare
A higher Medicare payment amount than 65% of clinicians listed under Otolaryngology in Rhode Island (2024, 20 clinicians with data). Median for this group: $65,689. Middle half: $17,624 to $88,354.
Too few clinicians listed under Otolaryngology in Warwick have Medicare Part B data for 2024 to compare.
Medicare Part D prescriptions
More Part D prescriptions than 95% of clinicians listed under Otolaryngology in Rhode Island (2024, 20 clinicians with data). Median for this group: 466. Middle half: 155 to 655.
Too few clinicians listed under Otolaryngology in Warwick have Medicare Part D data for 2024 to compare.
Part D drug cost
A higher Part D drug cost than 95% of clinicians listed under Otolaryngology in Rhode Island (2024, 20 clinicians with data). Median for this group: $10,632. Middle half: $2,481 to $35,730.
Too few clinicians listed under Otolaryngology in Warwick have Medicare Part D data for 2024 to compare.
6 active clinicians are listed under Otolaryngology with a practice address in Warwick, RI (30 in Rhode Island).
Addresses are self-reported to NPPES and may be out of date.
CMS data by year
Changes may reflect reporting, coverage or privacy limits, not changes in care quality.
-
Medicare Part B services
Medicare Part B services increased 22% from 861 in 2020 to 1,054 in 2024.
- 2020: 861
- 2021: 943
- 2022: 895
- 2023: 909
- 2024: 1,054
-
Medicare-allowed amount
Medicare-allowed amount increased 48% from $78,526 in 2020 to $116,089 in 2024.
- 2020: $78,526
- 2021: $97,655
- 2022: $90,981
- 2023: $95,925
- 2024: $116,089
-
Paid by Medicare
Paid by Medicare increased 48% from $58,220 in 2020 to $86,106 in 2024.
- 2020: $58,220
- 2021: $71,906
- 2022: $63,112
- 2023: $70,749
- 2024: $86,106
-
Medicare Part D prescriptions
Medicare Part D prescriptions increased 69% from 1,116 in 2020 to 1,883 in 2024.
- 2020: 1,116
- 2021: 1,318
- 2022: 1,386
- 2023: 1,503
- 2024: 1,883
-
30-day fills
30-day fills increased 90% from 1,768 in 2020 to 3,351 in 2024.
- 2020: 1,768
- 2021: 2,173
- 2022: 2,439
- 2023: 2,635
- 2024: 3,351
-
Part D drug cost
Part D drug cost increased 78% from $166,265 in 2020 to $295,363 in 2024.
- 2020: $166,265
- 2021: $127,605
- 2022: $147,981
- 2023: $211,709
- 2024: $295,363
-
Industry payments (Open Payments)
Industry payments (Open Payments) increased 38% from $1,999.47 in 2021 to $2,766.76 in 2025.
- 2021: $1,999.47
- 2022: $2,622.52
- 2023: $2,503.41
- 2024: $1,902.30
- 2025: $2,766.76
Sources: CMS Medicare Physician & Other Practitioners (2024), CMS Medicare Part D Prescribers (2024), CMS Open Payments (2025), CMS Doctors and Clinicians, CMS NPPES NPI Registry. Specialty names follow the NUCC Health Care Provider Taxonomy.
Text: T-MedInfo · Report an error.
Pharma & Medical Device Financial Disclosures
Payments and other transfers of value that drug and medical device companies reported to CMS Open Payments
Program year 2025 (payments made January 1 – December 31, 2025): 92 records totaling $2,766.76.
| Manufacturer | Payment Nature | Product | Type | Amount ($) |
|---|---|---|---|---|
| Inspire Medical Systems, Inc. |
Food and Beverage
In-kind items and services
|
INSPIRE | General | $168.67 |
| AstraZeneca Pharmaceuticals LP |
Food and Beverage
In-kind items and services
|
TEZSPIRE | General | $121.83 |
| GlaxoSmithKline, LLC. |
Food and Beverage
In-kind items and services
|
NUCALA | General | $121.83 |
| AstraZeneca Pharmaceuticals LP |
Food and Beverage
In-kind items and services
|
TEZSPIRE | General | $121.82 |
| GlaxoSmithKline, LLC. |
Food and Beverage
In-kind items and services
|
AREXVY | General | $109.32 |
| AstraZeneca Pharmaceuticals LP |
Food and Beverage
In-kind items and services
|
AIRSUPRA | General | $108.12 |
| Sanofi and Genzyme US Companies |
Food and Beverage
In-kind items and services
|
DUPIXENT | General | $89.47 |
| Stryker Corporation |
Food and Beverage
In-kind items and services
|
XPRESS LOPROFILE | General | $49.09 |
| AstraZeneca Pharmaceuticals LP |
Food and Beverage
In-kind items and services
|
AIRSUPRA | General | $44.29 |
| Sanofi and Genzyme US Companies |
Food and Beverage
In-kind items and services
|
DUPIXENT | General | $40.46 |
| Sanofi and Genzyme US Companies |
Food and Beverage
In-kind items and services
|
DUPIXENT | General | $39.72 |
| AstraZeneca Pharmaceuticals LP |
Food and Beverage
In-kind items and services
|
AIRSUPRA | General | $34.76 |
| AstraZeneca Pharmaceuticals LP |
Food and Beverage
In-kind items and services
|
AIRSUPRA | General | $34.26 |
| Sanofi and Genzyme US Companies |
Food and Beverage
In-kind items and services
|
DUPIXENT | General | $33.45 |
| Sanofi and Genzyme US Companies |
Food and Beverage
In-kind items and services
|
DUPIXENT | General | $32.92 |
| Sanofi and Genzyme US Companies |
Food and Beverage
In-kind items and services
|
DUPIXENT | General | $32.19 |
| GlaxoSmithKline, LLC. |
Food and Beverage
In-kind items and services
|
NUCALA | General | $31.66 |
| Sanofi and Genzyme US Companies |
Food and Beverage
In-kind items and services
|
DUPIXENT | General | $31.60 |
| Genentech, Inc. |
Food and Beverage
In-kind items and services
|
Xolair | General | $30.98 |
| Sanofi and Genzyme US Companies |
Food and Beverage
In-kind items and services
|
DUPIXENT | General | $30.50 |
| Sanofi and Genzyme US Companies |
Food and Beverage
In-kind items and services
|
DUPIXENT | General | $29.81 |
| Sanofi and Genzyme US Companies |
Food and Beverage
In-kind items and services
|
DUPIXENT | General | $29.38 |
| Pfizer Inc. |
Food and Beverage
In-kind items and services
|
NURTEC ODT | General | $29.28 |
| Sanofi and Genzyme US Companies |
Food and Beverage
In-kind items and services
|
DUPIXENT | General | $29.12 |
| AstraZeneca Pharmaceuticals LP |
Food and Beverage
In-kind items and services
|
AIRSUPRA | General | $29.07 |
(top 25 shown)
Source: CMS Open Payments, program year 2025, released June 30, 2026.
Performed Procedures & Service Volume
CPT® is a registered trademark of the American Medical Association. CPT codes, descriptions and other data only are copyright 2016–2023 American Medical Association. All rights reserved. Applicable FARS/HHSARS apply. Descriptions of CPT codes are the AMA's CPT Consumer Friendly Descriptors as published by CMS in the Medicare Physician & Other Practitioners – by Provider and Service data, 2017–2024; they are plain-language summaries, not for clinical coding or documentation. HCPCS Level II codes and descriptions are from CMS. Fee schedules, relative value units, conversion factors and/or related components are not assigned by the AMA, are not part of CPT, and the AMA is not recommending their use. The AMA does not directly or indirectly practice medicine or dispense medical services. The AMA assumes no liability for data contained or not contained herein.
| HCPCS Code | Services | Patients | Submitted Charge | Medicare Allowed |
|---|---|---|---|---|
|
99213
Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more
|
380 | 272 | $150.00 | $90.74 |
|
99214
Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
|
185 | 145 | $200.00 | $125.62 |
|
31231
Diagnostic exam of nasal passages using an endoscope
|
147 | 123 | $500.00 | $186.53 |
|
69210
Removal of impacted ear wax
|
105 | 68 | $120.00 | $45.44 |
|
99203
New patient office or other outpatient visit with low level of medical decision making, if using time, 30 minutes or more
|
66 | 66 | $225.00 | $110.91 |
|
31575
Diagnostic exam of voice box using a flexible endoscope
|
53 | 53 | $275.00 | $123.17 |
|
99204
New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more
|
44 | 44 | $275.00 | $162.27 |
|
99212
Established patient office or other outpatient visit with straightforward medical decision making, if using time, 10 minutes or more
|
30 | 25 | $125.00 | $57.22 |
|
99202
New patient office or other outpatient visit with straightforward medical decision making, if using time, 15 minutes or more
|
18 | 18 | $150.00 | $72.85 |
|
92511
Exam of the nose and throat using an endoscope
|
15 | 15 | $236.00 | $119.13 |
|
92557
Comprehensive hearing and speech recognition test
|
11 | 11 | $88.00 | $34.05 |
Source: CMS Part B by Provider and Service, 2024; services under 11 beneficiaries omitted by CMS. Privacy limits
Submitted charges are billed amounts, not a price quote for your visit.
Medicare Part D Prescribing Profile & Medications
Medicare Part D prescriptions filled, including refills, in 2024.
| Brand Name | Generic Name | Prescriptions | Day Supply | Total Cost | Patients |
|---|---|---|---|---|---|
| Fluticasone Propionate | Fluticasone Propionate | 509 | 32,730 | $9,883.66 | 195 |
| Ipratropium Bromide | Ipratropium Bromide | 332 | 18,845 | $18,348.60 | 145 |
| Azelastine Hcl | Azelastine Hcl | 266 | 16,220 | $8,841.42 | 101 |
| Montelukast Sodium | Montelukast Sodium | 73 | 5,450 | $867.79 | 20 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 72 | 2,062 | $2,574.74 | 19 |
| Omeprazole | Omeprazole | 62 | 4,440 | $692.09 | 18 |
| Xolair | Omalizumab | 62 | 1,736 | $186,553.73 | — |
| Rizatriptan | Rizatriptan Benzoate | 51 | 1,441 | $490.79 | 25 |
| Famotidine | Famotidine | 43 | 2,850 | $487.85 | 14 |
| Prednisone | Prednisone | 40 | 252 | $104.00 | 36 |
| Mometasone Furoate | Mometasone Furoate | 39 | 1,322 | $458.53 | 27 |
| Breo Ellipta | Fluticasone/Vilanterol | 34 | 1,260 | $16,282.56 | — |
| Gabapentin | Gabapentin | 32 | 960 | $201.80 | — |
| Xhance | Fluticasone Propionate | 31 | 930 | $18,627.68 | — |
| Arnuity Ellipta | Fluticasone Furoate | 29 | 1,290 | $9,771.25 | — |
| Neomycin-Polymyxin-Dexameth | Neomycin/Polymyxin B/Dexametha | 25 | 380 | $317.13 | 15 |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 23 | 224 | $208.40 | 21 |
| Epinephrine | Epinephrine | 18 | 266 | $2,286.85 | 17 |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 17 | 510 | $10,463.64 | — |
| Ofloxacin | Ofloxacin | 15 | 230 | $265.81 | 14 |
| Budesonide-Formoterol Fumarate | Budesonide/Formoterol Fumarate | 14 | 420 | $2,616.23 | — |
| Symbicort | Budesonide/Formoterol Fumarate | 13 | 390 | $3,302.49 | — |
| Mupirocin | Mupirocin | 13 | 281 | $128.65 | 12 |
| Methylprednisolone | Methylprednisolone | 12 | 72 | $34.34 | — |
| Clonazepam | Clonazepam | 12 | 330 | $37.27 | — |
(top 25 shown)
Source: CMS Part D by Provider and Drug, 2024; rows below 11 claims omitted by CMS; volume isn’t quality. Privacy limits
Specialties & License Numbers Reported to NPPES
NUCC Taxonomy Code: 207Y00000X
An otolaryngologist-head and neck surgeon provides comprehensive medical and surgical care for patients with diseases and disorders that affect the ears, nose, throat, the respiratory and upper alimentary systems and related structures of the head and neck. An otolaryngologist diagnoses and provides medical and/or surgical therapy or prevention of diseases, allergies, neoplasms, deformities, disorders and/or injuries of the ears, nose, sinuses, throat, respiratory and upper alimentary systems, face, jaws and the other head and neck systems. Head and neck oncology, facial plastic and reconstructive surgery and the treatment of disorders of hearing and voice are fundamental areas of expertise.
Additional State Medicaid & Healthcare Payer Identifiers
Medicare (PECOS) Enrollment & Ordering Eligibility
Source: CMS PECOSPRACTITIONER - OTOLARYNGOLOGY
I20070626000786
RI
6002915428
Sources: CMS Provider Enrollment and Order and Referring. Medicare enrollment is a billing status, not an accreditation or quality rating.
Medicare Group Practice Enrollments
Source: CMS Doctors and Clinicians National Downloadable File
Ent And Allergy Inc
3520 Post Rd, Warwick, RI 028867140
Phone: 4019215800
Clinicians Sharing This Practice Address or Phone
Clinicians sharing this NPPES address, phone or fax; a shared contact does not mean they work together.
Audiologist
Master of Science
Otolaryngology
Doctor of Medicine (M.D.)
Nurse Practitioner - Family
Advanced Practice Registered Nurse
Physician Assistant
Physician Assistant (Certified)
Audiologist
Doctor of Audiology
Otolaryngology
Doctor of Medicine (M.D.)
Career & Practice History
NPI enumerated January 05, 2007.
No changes to the name, practice address, taxonomy or NPI status in this record have been observed in the monthly NPPES data files from January 2017 to August 2026.
NPI Administrative Meta
Other Otolaryngology Specialists in Warwick
Healthcare providers in WarwickMailing Address
3520 Post Rd
Warwick, RI 028867140
Phone: 4019215800